AustralianSuper Pty Ltd

Position in BIIB — Biogen Inc.

CIK 1694164 MELBOURNE, C3

Position in BIIB

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$145,348,531

+$32,381,869 QoQ

Shares Held

672,723

+9.2% QoQ

Ownership

0.456%

of shares outstanding

% of Portfolio

0.63%

of 13F equity value

Holder Rank

#38

of 1,036 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AustralianSuper Pty Ltd holds $1,190,287,072 across 9 Drug Manufacturers - General names. BIIB ranks #3 (12.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	469,702	$563,374,716
2	GILD	Gilead Sciences, Inc.	1,271,457	$160,635,877
3	BIIB	Biogen Inc. This page	672,723	$145,348,531
4	BMY	Bristol Myers Squibb Co	2,433,354	$140,209,857
5	ABBV	AbbVie Inc.	426,658	$107,364,219
6	JNJ	Johnson & Johnson	152,900	$38,832,013
7	PFE	Pfizer Inc	968,550	$23,322,684
8	MRK	Merck & Co., Inc.	77,831	$10,001,283

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$145,348,531	672,723	+9.2%	Shares	Sole	2026-08-12
2026-03-31	$112,966,662	616,193	+29.2%	Shares	Sole	2026-05-07
2025-12-31	$83,914,143	476,812	-36.5%	Shares	Sole	2026-02-05
2025-09-30	$105,254,150	751,386	+1.6%	Shares	Sole	2025-11-12
2025-06-30	$92,863,255	739,416	+85.9%	Shares	Sole	2025-08-01
2025-03-31	$54,420,857	397,697	+21763.5%	Shares	Sole	2025-05-05
2023-06-30	$518,142	1,819	-99.1%	Shares	Sole	2023-07-28
2021-12-31	$46,031,291	191,861	-24.8%	Shares	Sole	2022-01-24
2021-09-30	$72,161,601	254,997	-6.4%	Shares	Sole	2021-11-12
2021-06-30	$94,363,076	272,513	-46.3%	Shares	Sole	2021-08-12
2021-03-31	$142,051,175	507,779	+264.1%	Shares	Sole	2021-05-14
2020-12-31	$34,152,093	139,476	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.